Zobrazeno 1 - 10
of 462
pro vyhledávání: '"Mallard N"'
Autor:
Crystal, David
Publikováno v:
The Oxford Dictionary of Original Shakespearean Pronunciation, 1 ed., 2016.
Autor:
Bulhosen, Pat, Logi, Francesca, Riu, Loredana
Publikováno v:
Pocket Oxford Italian Dictionary: English-Italian, 4 ed., 2012.
Autor:
Clack G; TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK. G.Clack@theracryf.com., Moore C; Boyds, Crewe, UK., Ruston L; Seda Pharmaceutical Development Services, Stockport, UK., Wilson D; DJWstats Consulting, Whaley Bridge, UK., Koch A; Simbec-Orion, Merthyr Tydfil, UK., Webb D; Simbec-Orion, Merthyr Tydfil, UK., Mallard N; TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK.
Publikováno v:
Advances in therapy [Adv Ther] 2024 Nov 09. Date of Electronic Publication: 2024 Nov 09.
Publikováno v:
Agrobiological Records. Apr-Jun2023, Vol. 12, p9-21. 13p.
Autor:
Adlhoch, Cornelia, Fusaro, Alice, Gonzales, José L., Kuiken, Thijs, Marangon, Stefano, Niqueux, Éric, Staubach, Christoph, Smietanka, Krzysztof, Terregino, Calogero, Van der Stede, Yves, Aznar, Inma, Baldinelli, Francesca
Publikováno v:
EFSA Journal. Nov2020, Vol. 18 Issue 11, p1-20. 20p.
Autor:
Stallknecht, David E.1, Carter, Deborah L.1, Blake-Bradshaw, Abigail G.2, Masto, Nicholas M.3, Highway, Cory J.2, Feddersen, Jamie C.4, Webby, Richard5, Cohen, Bradley2, Sullivan, Jeffery D.6, Poulson, Rebecca L.1 rpoulson@uga.edu
Publikováno v:
Emerging Infectious Diseases. Dec2024, Vol. 30 Issue 12, p2647-2650. 4p.
Autor:
Malcolm Boyce, D G MacMahon, E S Johnson, A Clarke, SJ Warrington, T H Corn, Mallard N, Atholl Johnston
Publikováno v:
Journal of Neural Transmission. 110:1257-1271
Three studies were performed using a fast dissolving formulation of selegiline hydrochloride designed for buccal absorption "Zydis Selegiline". The aim of the first study was to compare the therapeutic efficacy of Zydis Selegiline (1.25 mg or 10 mg)
Publikováno v:
Journal of Neural Transmission. 110:1241-1255
Seven randomised comparative studies were conducted in healthy volunteers to compare the pharmacokinetic and pharmacodynamic profiles of selegiline hydrochloride in a new formulation designed for buccal absorption "Zydis Selegiline" (1.25-10 mg) with
Autor:
Ma, Lingyan1 (AUTHOR), Lyu, Wentao1 (AUTHOR), Zeng, Tao2 (AUTHOR), Wang, Wen1 (AUTHOR), Chen, Qu1 (AUTHOR), Zhao, Jiangchao3 (AUTHOR), Zhang, Guolong4 (AUTHOR), Lu, Lizhi2 (AUTHOR) lulizhibox@163.com, Yang, Hua1 (AUTHOR) yanghua@zaas.ac.cn, Xiao, Yingping1 (AUTHOR) xiaoyp@zaas.ac.cn
Publikováno v:
iMeta. Aug2024, Vol. 3 Issue 4, p1-23. 23p.
Autor:
Cross, Samuel R. R.1 (AUTHOR) Samuel.Cross@liverpool.ac.uk, Marmol-Guijarro, Andres C.2,3,4,5 (AUTHOR), Bates, Karl T.1 (AUTHOR), Marrin, John C.6 (AUTHOR), Tickle, Peter G.2 (AUTHOR), Rose, Kayleigh A.7 (AUTHOR), Codd, Jonathan R.2 (AUTHOR)
Publikováno v:
Communications Biology. 7/24/2024, Vol. 7 Issue 1, p1-14. 14p.